Cargando…

Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms

The correct balance between reactive oxygen species and antioxidant defense in an organism is disturbed in oxidative stress. To assess oxidative balance in 36 SSc patients and 26 healthy controls (HCs), we measured reactive oxidative metabolites (ROMs), total antioxidant capacity (TAC), lipid peroxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brezovec, Neža, Perdan-Pirkmajer, Katja, Burja, Blaž, Rotar, Žiga, Osredkar, Joško, Sodin-Šemrl, Snežna, Lakota, Katja, Čučnik, Saša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452464/
https://www.ncbi.nlm.nih.gov/pubmed/37626607
http://dx.doi.org/10.3390/biomedicines11082110
_version_ 1785095677686054912
author Brezovec, Neža
Perdan-Pirkmajer, Katja
Burja, Blaž
Rotar, Žiga
Osredkar, Joško
Sodin-Šemrl, Snežna
Lakota, Katja
Čučnik, Saša
author_facet Brezovec, Neža
Perdan-Pirkmajer, Katja
Burja, Blaž
Rotar, Žiga
Osredkar, Joško
Sodin-Šemrl, Snežna
Lakota, Katja
Čučnik, Saša
author_sort Brezovec, Neža
collection PubMed
description The correct balance between reactive oxygen species and antioxidant defense in an organism is disturbed in oxidative stress. To assess oxidative balance in 36 SSc patients and 26 healthy controls (HCs), we measured reactive oxidative metabolites (ROMs), total antioxidant capacity (TAC), lipid peroxidation (measuring 4-HNE), and DNA oxidative damage (measuring 8-OHdG) in serum. Furthermore, DNA breaks in leukocytes of 35 SSc patients and 32 HCs were evaluated using COMET. While we report high ROMs for both SSc patients and age/sex matched HC samples, there was a significant increase in TAC in SSc patients as compared to HCs, and thus also a significantly higher oxidative stress index in SSc patients. TAC was significantly higher in SSc patients with ILD and gastrointestinal involvement, as well as in patients with anti-topoisomerase antibodies. We observe no difference in serum lipid peroxidation status or oxidative DNA damage. However, SSc patients had significantly more leukocyte DNA breaks than HCs; the most damage was observed in patients treated with immunosuppressives. Thus, our study confirms presence of oxidative stress and increased DNA damage in leukocytes of SSc patients; however, it points toward increased antioxidant capacity, which needs to be further studied.
format Online
Article
Text
id pubmed-10452464
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104524642023-08-26 Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms Brezovec, Neža Perdan-Pirkmajer, Katja Burja, Blaž Rotar, Žiga Osredkar, Joško Sodin-Šemrl, Snežna Lakota, Katja Čučnik, Saša Biomedicines Article The correct balance between reactive oxygen species and antioxidant defense in an organism is disturbed in oxidative stress. To assess oxidative balance in 36 SSc patients and 26 healthy controls (HCs), we measured reactive oxidative metabolites (ROMs), total antioxidant capacity (TAC), lipid peroxidation (measuring 4-HNE), and DNA oxidative damage (measuring 8-OHdG) in serum. Furthermore, DNA breaks in leukocytes of 35 SSc patients and 32 HCs were evaluated using COMET. While we report high ROMs for both SSc patients and age/sex matched HC samples, there was a significant increase in TAC in SSc patients as compared to HCs, and thus also a significantly higher oxidative stress index in SSc patients. TAC was significantly higher in SSc patients with ILD and gastrointestinal involvement, as well as in patients with anti-topoisomerase antibodies. We observe no difference in serum lipid peroxidation status or oxidative DNA damage. However, SSc patients had significantly more leukocyte DNA breaks than HCs; the most damage was observed in patients treated with immunosuppressives. Thus, our study confirms presence of oxidative stress and increased DNA damage in leukocytes of SSc patients; however, it points toward increased antioxidant capacity, which needs to be further studied. MDPI 2023-07-26 /pmc/articles/PMC10452464/ /pubmed/37626607 http://dx.doi.org/10.3390/biomedicines11082110 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Brezovec, Neža
Perdan-Pirkmajer, Katja
Burja, Blaž
Rotar, Žiga
Osredkar, Joško
Sodin-Šemrl, Snežna
Lakota, Katja
Čučnik, Saša
Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
title Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
title_full Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
title_fullStr Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
title_full_unstemmed Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
title_short Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
title_sort disturbed antioxidant capacity in patients with systemic sclerosis associates with lung and gastrointestinal symptoms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452464/
https://www.ncbi.nlm.nih.gov/pubmed/37626607
http://dx.doi.org/10.3390/biomedicines11082110
work_keys_str_mv AT brezovecneza disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT perdanpirkmajerkatja disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT burjablaz disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT rotarziga disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT osredkarjosko disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT sodinsemrlsnezna disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT lakotakatja disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms
AT cucniksasa disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms